USPTO Office Action, and Myriad Genetics' Subsequent Response

dc.contributor.author

United States Patent and Trade Office

dc.contributor.author

Myriad Genetics, Inc.

dc.date.accessioned

2013-07-16T01:50:17Z

dc.date.available

2013-07-16T01:50:17Z

dc.date.issued

1997

dc.description

The USPTO requested that Myriad restrict its application to one invention, and suggested ways to group claims in distinct inventions; Myriad responded with alternate combinations of claims into fewer new distinct inventions.

dc.identifier.uri

https://hdl.handle.net/10161/7674

dc.language.iso

en_US

dc.subject

Genetics, Myriad Genetics, BRCA, Breast Cancer, Gene Patents, Law, Health Policy, Medicine, Women’s Health

dc.title

USPTO Office Action, and Myriad Genetics' Subsequent Response

dc.type

Other

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pto office action and myriad's response.Jan 6 and Feb 5 1997.pdf
Size:
464.2 KB
Format:
Adobe Portable Document Format
Description:
USPTO Office Action and Myriad's Response